Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Am J Trop Med Hyg ; 104(4): 1582-1585, 2021 03 01.
Article in English | MEDLINE | ID: mdl-33646978

ABSTRACT

Bloodstream infections cause substantial morbidity and mortality. However, despite clinical suspicion of such infections, blood cultures are often negative. We investigated blood cultures that were negative after 5 days of incubation for the presence of bacterial pathogens using specific (Rickettsia spp. and Leptospira spp.) and a broad-range 16S rRNA PCR. From 190 samples, 53 (27.9%) were positive for bacterial DNA. There was also a high background incidence of dengue (90/112 patient serum positive, 80.4%). Twelve samples (6.3%) were positive for Rickettsia spp., including two Rickettsia typhi. The 16S rRNA PCR gave 41 positives; Escherichia coli and Klebsiella pneumoniae were identified in 11 and eight samples, respectively, and one Leptospira species was detected. Molecular investigation of negative blood cultures can identify potential pathogens that will otherwise be missed by routine culture. Patient management would have been influenced in all 53 patients for whom a bacterial organism was identified, and 2.3-6.1% of patients would likely have had an altered final outcome. These findings warrant further study, particularly to determine the cost-benefit for routine use, ways of implementation, and timing of PCR for organisms such as Rickettsia and Leptospira, which are important pathogens in rural Asia.


Subject(s)
Blood Culture/statistics & numerical data , DNA, Bacterial/analysis , DNA, Bacterial/genetics , Escherichia coli/genetics , Escherichia coli/pathogenicity , Humans , Laos/epidemiology , Leptospira/genetics , Leptospira/pathogenicity , Pathology, Molecular , Polymerase Chain Reaction , RNA, Ribosomal, 16S/genetics , Rickettsia/genetics , Rickettsia/pathogenicity , Rickettsia typhi/genetics , Rickettsia typhi/pathogenicity
2.
BMC Infect Dis ; 21(1): 173, 2021 Feb 12.
Article in English | MEDLINE | ID: mdl-33579205

ABSTRACT

BACKGROUND: Blood cultures are one of the most important tests performed by microbiology laboratories. Many hospitals, particularly in low and middle-income countries, lack either microbiology services or staff to provide 24 h services resulting in delays to blood culture incubation. There is insufficient guidance on how to transport/store blood cultures if delays before incubation are unavoidable, particularly if ambient temperatures are high. This study set out to address this knowledge gap. METHODS: In three South East Asian countries, four different blood culture systems (two manual and two automated) were used to test blood cultures spiked with five common bacterial pathogens. Prior to incubation the spiked blood culture bottles were stored at different temperatures (25 °C, in a cool-box at ambient temperature, or at 40 °C) for different lengths of time (0 h, 6 h, 12 h or 24 h). The impacts of these different storage conditions on positive blood culture yield and on time to positivity were examined. RESULTS: There was no significant loss in yield when blood cultures were stored < 24 h at 25 °C, however, storage for 24 h at 40 °C decreased yields and longer storage times increased times to detection. CONCLUSION: Blood cultures should be incubated with minimal delay to maximize pathogen recovery and timely result reporting, however, this study provides some reassurance that unavoidable delays can be managed to minimize negative impacts. If delays to incubation ≥ 12 h are unavoidable, transportation at a temperature not exceeding 25 °C, and blind sub-cultures prior to incubation should be considered.


Subject(s)
Blood Culture/standards , Specimen Handling/standards , Asia, Southeastern , Bacteria/classification , Bacteria/isolation & purification , Blood Culture/statistics & numerical data , Clinical Laboratory Services/standards , Clinical Laboratory Services/statistics & numerical data , Humans , Specimen Handling/statistics & numerical data , Temperature , Time Factors
3.
Int J Infect Dis ; 95: 198-203, 2020 Jun.
Article in English | MEDLINE | ID: mdl-32278109

ABSTRACT

OBJECTIVES: Invasive disease caused by Neisseria meningitidis is a significant health concern globally, but our knowledge of the prevailing serogroups, antimicrobial susceptibility patterns, and genetics of N. meningitidis in Southeast Asia is limited. Chloramphenicol resistance in N. meningitidis has rarely been reported, but was first described in isolates from Vietnam in 1998. We aimed to characterise eight chloramphenicol resistant meningococcal isolates collected between 2007 and 2018 from diagnostic microbiology laboratories in Cambodia, Thailand and the Lao People's Democratic Republic (Laos). METHODS: Whole-genome sequencing was used to generate genome sequences from 18 meningococcal isolates including the eight chloramphenicol resistant isolates. We identified antimicrobial resistance genes present in these strains, and examined the phylogenetic relationships between strains. RESULTS: The eight resistant strains all contain the same chloramphenicol resistance gene first described in 1998, and are closely related to each other. Strains resistant to penicillin, tetracycline, and ciprofloxacin were also observed, including a chloramphenicol-resistant strain which has acquired penicillin and ciprofloxacin resistance. CONCLUSIONS: This study suggests that chloramphenicol-resistant N. meningitidis is more widespread than previously thought, and that the previously-identified resistant lineage is now found in multiple countries in Southeast Asia.


Subject(s)
Chloramphenicol Resistance/genetics , Neisseria meningitidis/drug effects , Neisseria meningitidis/isolation & purification , Asia, Southeastern , Child , Child, Preschool , Drug Resistance, Multiple, Bacterial , Female , Humans , Infant , Infant, Newborn , Male , Middle Aged , Neisseria meningitidis/classification , Neisseria meningitidis/genetics , Phylogeny , Serogroup
4.
PLoS Negl Trop Dis ; 13(7): e0007598, 2019 07.
Article in English | MEDLINE | ID: mdl-31306412

ABSTRACT

BACKGROUND: Melioidosis is a frequently fatal disease requiring specific treatment. The yield of Burkholderia pseudomallei from sites with a normal flora is increased by culture using selective, differential media such as Ashdown's agar and selective broth. However, since melioidosis mainly affects people in resource-poor countries, the cost effectiveness of selective culture has been questioned. We therefore retrospectively evaluated this in two laboratories in southeast Asia. METHODOLOGY/PRINCIPAL FINDINGS: The results of all cultures in the microbiology laboratories of Mahosot Hospital, Vientiane, Laos and Angkor Hospital for Children, Siem Reap, Cambodia, in 2017 were reviewed. We identified patients with melioidosis who were only diagnosed as a result of culture of non-sterile sites and established the total number of such samples cultured using selective media and the associated costs in each laboratory. We then conducted a rudimentary cost-effectiveness analysis by determining the incremental cost-effectiveness ratio (ICER) per DALY averted and compared this against the 2017 GDP per capita in each country. Overall, 29 patients in Vientiane and 9 in Siem Reap (20% and 16.9% of all culture-positive patients respectively) would not have been diagnosed without the use of selective media, the majority of whom (18 and 8 respectively) were diagnosed by throat swab culture. The cost per additional patient detected by selective culture was approximately $100 in Vientiane and $39 in Siem Reap. Despite the different patient populations (all ages in Vientiane vs. only children in Siem Reap) and testing strategies (all samples in Vientiane vs. based on clinical suspicion in Siem Reap), selective B. pseudomallei culture proved highly cost effective in both settings, with an ICER of ~$170 and ~$28 in Vientiane and Siem Reap, respectively. CONCLUSIONS/SIGNIFICANCE: Selective culture for B. pseudomallei should be considered by all laboratories in melioidosis-endemic areas. However, the appropriate strategy for implementation should be decided locally.


Subject(s)
Burkholderia pseudomallei/isolation & purification , Clinical Laboratory Techniques/economics , Cost-Benefit Analysis , Culture Media/economics , Melioidosis/diagnosis , Bacteriological Techniques/economics , Bacteriological Techniques/methods , Burkholderia pseudomallei/growth & development , Cambodia , Clinical Laboratory Techniques/methods , Hospitals , Humans , Laos , Retrospective Studies , Specimen Handling
SELECTION OF CITATIONS
SEARCH DETAIL